最新ニュース AmpliTech Gr (NASDAQ:AMPG) 株価情報

AmpliTech Gr

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

AmpliTech Group Inc

WIIM

Warner Bros. Discovery shares are trading higher after the company announced it authorized a new corporate structure. Also, Guggenheim maintained a Buy rating on the stock and raised its price target from $11 to $12.5.

Guggenheim analyst Michael Schmidt reiterates Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) from Buy to Buy.

News

Reiteration

Analyst Ratings

ARVN

Guggenheim Reiterates Buy on Arvinasto Buy

Scotiabank analyst Andrew Weisel maintains Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) with a Sector Perform and raises the price target from $144 to $165.

Price Target

Scotiabank Maintains Sector Perform on Entergy, Raises Price Target to $165

Goldman Sachs analyst Joe Ritchie upgrades Flowserve (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLS#NYSE">FLS</a>) from Sell to Neutral and raises the price target from $55 to $69.

Upgrades

Goldman Sachs Upgrades Flowserve to Neutral, Raises Price Target to $69

Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), an American electronic design automation company, is preparing to divest an Ansys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>) unit, along with one of its own, to secure EU approval for <a href="https://www.benzinga.com/topic/mergers-and-acquisitions">its $35 billion acquisition,</a> according to sources cited by Reuters. Ansys specializes in software development for autonomous vehicle sensor simulations, including lidar, radar, and camera design.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12035939/newplot-10.png" alt="" class="wp-image-689110" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12035939/newplot-10.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12035939/newplot-10-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
The European Commission is awaiting feedback from rivals and customers on Synopsys&#8217; proposal.
Also Read: <a href="https://www.benzinga.com/24/12/42446573/similarwebs-product-upgrades-and-daas-expansion-drive-analyst-bullishness" target="_blank" rel="noreferrer noopener">Goldman Sachs Initiates Similarweb Coverage, Product Upgrades Inspire Bullish Take</a>
Responses are due by Dec.16.
Synopsys agreed to sell its optical design tool maker, Optical Solutions Group, to design and emulation company Keysight Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>).
It has now also offered to divest Ansys PowerArtist, including its research, development, distribution, licensing, selling, and marketing. PowerArtist is a tool for analyzing and reducing power to enable power-efficient design.
Synopsys expects the Ansys deal to close in the first half of 2025, Reuters reports.
Synopsys did not offer any behavioral remedies for its business practices, implying no regulatory objection regarding interoperability and product bundling.
In January 2024, Synopsys <a target="_blank" href="https://www.benzinga.com/m-a/24/01/36646413/why-is-ansys-stock-trading-lower-tuesday" rel="noreferrer noopener">agreed to acquire</a> Ansys for $35 billion through $19 billion in cash and $16 billion in debt.
In May, Synopsys <a href="https://www.benzinga.com/news/24/05/38650313/chip-designer-synopsys-sells-its-software-integrity-business-for-2-1b" target="_blank" rel="noreferrer noopener">forged a deal</a> to sell its Software Integrity Group business to Clearlake Capital Group and Francisco Partners for about $2.1 billion.
In October, the UK&#8217;s antitrust watchdog <a href="https://www.benzinga.com/government/24/10/41549838/uk-launches-antitrust-review-of-synopsys-34-billion-ansys-deal-over-growing-concerns" target="_blank" rel="noreferrer noopener">launched an inquiry</a> into the Synopsys-Ansys deal, citing antitrust concerns.
Synopsys held $4.05 billion in cash and equivalents as of <a href="https://www.benzinga.com/pressreleases/24/12/n42326148/synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2024" target="_blank" rel="noreferrer noopener">Oct. 31, 2024</a>. It expects first-quarter revenue of $1.435 billion-$1.465 billion, below the consensus estimates of $1.643 billion, and adjusted EPS of $2.77-$2.82 below the forecast of $3.53.
<a href="https://www.benzinga.com/government/24/11/41685490/nvidias-run-ai-acquisition-draws-european-regulatory-scrutiny-on-competition-concerns" target="_blank" rel="noreferrer noopener">Recent mergers, acquisitions, and investments</a> by Big Tech giants have attracted global antitrust scrutiny. The EU is reviewing Nvidia Corp&#8216;s Run:ai deal over possible stifling of competition in the AI space.
The Federal Trade Commission (FTC) is examining investments by Big Tech giants, including Microsoft Corp, Amazon.com Inc and Google parent Alphabet Inc into AI startups.
Price Actions:&nbsp;ANSS stock closed higher by 1.27% at $344.00 at Wednesday. SNPS closed higher by 1.33%.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/downgrades/24/12/42446502/e2open-faces-organic-growth-challenges-debt-overhang-goldman-sachs-downgrades-stock" target="_blank" rel="noreferrer noopener">E2open Faces Organic Growth Challenges, Debt Overhang: Goldman Sachs Downgrades Stock</a></li>
</ul>
Photo: Shutterstock

Government

Regulations

Eurozone

Asset Sales

Tech

ANSS

KEYS

SNPS

Synopsys Proposes Divesting Units, Including Ansys PowerArtist, For $35 Billion EU Deal Approval

CIEN

Ciena shares are trading higher after the company reported better-than-expected Q4 sales results. The stock initially traded lower, but it has since reversed.

Warren Buffett Says ‘Periodic Setbacks' Are Bound To Occur – But &#8216;The Risks of Being Out Of The Game Are Huge Compared To Being In'
In his 2012 shareholder letter, Warren Buffett delivered a <a href="https://www.benzinga.com/personal-finance/24/11/42191171/warren-buffett-claims-he-killed-the-dow-investing-peanuts-and-explains-its-a-huge-structural-advantage-to-not-have-a-lot-of-money">clear message to investors</a>: don't let short-term uncertainty or the predictions of so-called experts keep you on the sidelines. His advice was grounded in his experiences and decades of observing the market's resilience.
"Since the basic game is so favorable, Charlie and I believe it's a terrible mistake to try to dance in and out of it based upon the turn of tarot cards, the predictions of ‘experts' or the ebb and flow of business activity," Buffett wrote. "The risks of being out of the game are huge compared to the risks of being in it."
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
Buffett's example goes back to 1942 when he <a href="https://www.benzinga.com/markets/24/08/40417722/what-you-can-learn-from-14-year-old-warren-buffetts-first-real-estate-investment">first purchased stock</a>. The United States was deep into World War II and the situation in the Pacific looked grim. Headlines were filled with losses and uncertainty, but Buffett saw beyond the immediate chaos. He invested despite the dire circumstances, trusting in America's long-term economic strength.
"Each day's headlines told of more setbacks. Even so, there was no talk about uncertainty; every American I knew believed we would prevail," he reflected in the letter.
At the time of his 2012 letter, the U.S. was recovering from the 2008 financial crisis. Yet, Buffett's message wasn't limited to that moment – it was a reminder of the broader historical context. He noted that the Dow Jones Industrial Average had skyrocketed from 66 to 11,497 during the 20th century, an increase of 17,320%. This monumental growth happened despite numerous crises, including the Great Depression, World Wars and multiple recessions.
See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
This perspective is particularly relevant today, as investors face uncertainties from inflation to global conflicts and tech sector turbulence. Buffett argues that trying to time the market based on short-term fear or so-called expert forecasts risks missing out on the inevitable long-term growth.
Even in 2012, Buffett was critical of CEOs who hesitated to invest due to perceived uncertainty, saying:
"There was a lot of hand-wringing last year among CEOs who cried ‘uncertainty' when faced with capital-allocation decisions. At Berkshire, we didn't share their fears, instead spending a record $9.8 billion on plant and equipment in 2012."
Buffett's "stay in the game" philosophy resonates because it's rooted in data, not optimism for optimism's sake. Historically, markets have rewarded patience. Missing just a handful of the best-performing days over decades can significantly reduce overall returns. Buffett argues that you benefit from the compounding effect of time and growth by staying invested.
Trending: Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.
This advice contrasts sharply with the current environment of 24/7 news cycles and countless market analysts making bold – and often wrong – predictions. Many investors get caught up in the noise, forgetting the long-term fundamentals.
Buffett's first investment in 1942 was modest – just three shares of Cities Service Preferred for $114.75. Over the next eight decades, the market endured wars, recessions and major financial crises, yet it delivered substantial gains for those who stayed the course.
In 2024, while <a href="https://www.benzinga.com/real-estate/24/10/41455464/warren-buffett-said-hed-buy-a-couple-hundred-thousand-single-family-homes-if-he-could-and-hed-take-o">challenges may look different</a>, Buffett's strategy remains relevant: invest consistently and ignore the noise. As he said, "Periodic setbacks will occur, yes, but investors and managers are in a game that is heavily stacked in their favor."
For Buffett, the greatest risk isn't the market's ups and downs – it's <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">being out of it altogether</a>.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest TODAY for just $0.26/share with a $1000 minimum.</a></li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Warren Buffett Says Ignore 'Tarot' Card Predictions by So-Called Experts: 'The Risks of Being Out of the Game Are Huge Compared to Being In'

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Thursday.
Following the market opening Thursday, the Dow traded down 0.01% to 44,142.13 while the NASDAQ fell 0.27% to 19,979.88. The S&amp;P 500 also fell, dropping, 0.14% to 6,075.73.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a>
Leading and Lagging Sectors Real estate shares jumped by 0.7% on Thursday.
In trading on Thursday, energy shares fell by 0.7%.
Top Headline
U.S. initial jobless claims increased by 17,000 from the previous week to a reading of 242,000 during the first week of December, compared to market estimates of 220,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Palisade Bio, Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) shares shot up 73% to $2.42.</li>
<li>Shares of Trevi Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) got a boost, surging 62% to $4.0435 after the company announced positive outcomes for the treatment of patients from its chronic cough Phase 2b CORAL trial.</li>
<li>Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) shares were also up, gaining 52% to $0.1980.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sacks Parente Golf, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) shares dropped 80% to $0.28 after the company priced an upsized $8.4 million underwritten public offering of 7 million common units at $1.20 per unit.</li>
<li>Shares of Keros Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) were down 76% to $16.57 after the company announced it halted treatment in the 3.0 mg/kg and 4.5 mg/kg arms of its ongoing TROPOS trial due to safety concerns..</li>
<li>TFF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) was down, falling 55% to $0.0740.</li>
</ul>
Commodities In commodity news, oil traded down 1.3% to $69.35 while gold traded down 1.7% at $2,709.80.
Silver traded down 3.7% to $31.710 on Thursday, while copper fell 0.8% to $4.2245.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 fell 0.1%, Germany's DAX rose 0.2% and France's CAC 40 gained 0.2%. Spain's IBEX 35 Index slipped 0.1%, while London's FTSE 100 rose 0.2%.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 gaining 1.21%, Hong Kong's Hang Seng Index gaining 1.20%, China's Shanghai Composite Index gaining 0.85% and India's BSE Sensex falling 0.29%.
Economics
<ul>
<li>U.S. initial jobless claims increased by 17,000 from the previous week to a reading of 242,000 during the first week of December, compared to market estimates of 220,000.</li>
<li>Core producer prices increased by 0.2% month-over-month in November compared to a 0.3% increase in the previous month and in-line with market expectations.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42460506/wall-streets-most-accurate-analysts-weigh-in-on-3-risk-off-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Risk Off Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Earnings

Equities

Commodities

Intraday Update

Markets

Trading Ideas

GOEV

KROS

PALI

SPGC

TFFP

TRVI

Nasdaq Down 50 Points; US Initial Jobless Claims Rise

Guggenheim analyst Seamus Fernandez reiterates Apogee Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APGE#NASDAQ">APGE</a>) from Buy to Buy.

APGE

Guggenheim Reiterates Buy on Apogee Therapeuticsto Buy

Goldman Sachs analyst Duffy Fischer maintains Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) with a Neutral and lowers the price target from $56 to $48.

Goldman Sachs Maintains Neutral on Dow, Lowers Price Target to $48

Goldman Sachs analyst Joe Ritchie maintains Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) with a Buy and raises the price target from $202 to $223.

Goldman Sachs Maintains Buy on Dover, Raises Price Target to $223

Scotiabank analyst Andrew Weisel maintains Duke Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) with a Sector Perform and raises the price target from $113 to $120.

Scotiabank Maintains Sector Perform on Duke Energy, Raises Price Target to $120

Guggenheim analyst John Heinbockel reiterates United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) from Neutral to Neutral.

UNFI

Guggenheim Reiterates Neutral on United Natural Foodsto Neutral

Scotiabank analyst Andrew Weisel maintains DTE Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTE#NYSE">DTE</a>) with a Sector Outperform and raises the price target from $137 to $147.

Scotiabank Maintains Sector Outperform on DTE Energy, Raises Price Target to $147

Goldman Sachs analyst Noah Poponak maintains Booz Allen Hamilton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) with a Buy and lowers the price target from $210 to $158.

Goldman Sachs Maintains Buy on Booz Allen Hamilton, Lowers Price Target to $158

Scotiabank analyst Andrew Weisel maintains Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) with a Sector Perform and raises the price target from $58 to $61.

Scotiabank Maintains Sector Perform on Dominion Energy, Raises Price Target to $61

Scotiabank analyst Andrew Weisel maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Sector Outperform and raises the price target from $75 to $77.

Scotiabank Maintains Sector Outperform on CMS Energy, Raises Price Target to $77

Goldman Sachs analyst Susan Maklari maintains AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) with a Buy and raises the price target from $52 to $59.

AZEK

Goldman Sachs Maintains Buy on AZEK Co, Raises Price Target to $59

Scotiabank analyst Andrew Weisel maintains Black Hills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKH#NYSE">BKH</a>) with a Sector Perform and raises the price target from $63 to $67.

Scotiabank Maintains Sector Perform on Black Hills, Raises Price Target to $67

Goldman Sachs analyst James Schneider maintains American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) with a Buy and lowers the price target from $260 to $234.

Goldman Sachs Maintains Buy on American Tower, Lowers Price Target to $234

AmpliTech Group (AMPG) received an initial Purchase Order, as part of the recently announced signing of a 5 Year Basic Order Agreement, with a US b...

AmpliTech Group secures initial purchase order with Fortune 1000 U.S. company

AmpliTech secures initial purchase order under 5-year basic order agreement

AmpliTech Group (AMPG) has entered into one or more securities purchase agreements with certain institutional investors to purchase 1,603,259 share...

AmpliTech Group to sell 1.6M shares at 92c in registered direct offering

AmpliTech Group ( ($AMPG) ) has issued an update. AmpliTech Group, a leader in RF microwave components and 5G network solutions, announced a $1.4 m...

AmpliTech Group Announces $1.4M Direct Offering

AmpliTech Group (AMPG) announces the development and deployment of its proprietary low-noise cryogenic High Electron Mobility Transistor amplifiers...

AmpliTech Group announces development, deployment of HEMT amplifiers

AmpliTech Group (AMPG) announced that it has entered into one or more securities purchase agreements with certain institutional investors to purcha...

AmpliTech Group prices $2.2M registered direct offering

AmpliTech Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPG#NASDAQ">AMPG</a>) shares were on a moon mission on Wednesday, skyrocketing 94%. The reason behind the jump has to do with a very buzzy ...

Can AmpliTech Stock Jump Another ~100%? Here's What This Analyst Expects

AmpliTech Group jumps 40%, prices $2.2M direct stock offering

AmpliTech Group to sell 1.353M shares at $1.60 in registered direct offering

An update from AmpliTech Group ( ($AMPG) ) is now available. AmpliTech Group announced the pricing of a $2.2 million registered direct offering, se...

AmpliTech Group Announces $2.2 Million Stock Offering

AMPG

AMPGW

Legal

Press Releases

AmpliTech Group Announces Receipt of Notice of Allowance for Patents in 5G and Cryogenic Technology For Quantum Computing Applications

Contracts

AmpliTech Group's AGTGSS Division Signs 5 Year Supplier Agreement With Fujitsu Spain For Private 5G Network Products

General

AmpliTech Group's AGTGSS Division Releases New Portable 5G Networks In A Box (NIB) For Military, First Responders, And On-Demand Commercial Events

AmpliTech Group's AmpliTech Inc Division Signs 5 Year BOA (Basic Order Agreement) With Fortune 1000 US Company For LNB Products

AmpliTech Group Reports 2.8M revenue, 1.3M Gross profits, 47% Gross Margins

AmpliTech Group's AmpliTech Inc. Division Secures Initial Purchase Order Under 5-Year Basic Order Agreement With Fortune 1000 U.S. Company

AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market

Financing

AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering

AmpliTech Group Powers The Quantum Computing Revolution With Cutting-Edge Low-Noise Cryogenic HEMT Amplifiers

AmpliTech Group Announces Pricing of $2.2 Million Registered Direct Offering

Airgain

Akoustis Technologies, Inc. - Common Stock

Akoustis Technologies

Amphenol

Belden

Bel Fuse

CCSC Technology International Holdings Limited - Class A Ordinary Shares

CCSC Technology

Coherent

CPS Technologies

Corning

Knowles

Littelfuse

LGL Group

LG Display Co, Ltd AMERICAN DEPOSITORY SHARES

LG Display Co

Lightwave Logic

M-Tron Industries

Ostin Technology Group Co., Ltd. - Class A Ordinary Shares

Ostin Technology Group

Rogers

Vishay Intertechnology, Inc. Common Stock

Comments

AmpliTech Gr

ニュース

最新ニュース AmpliTech Gr (NASDAQ:AMPG) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル